THE SMART TRICK OF MBL77 THAT NOBODY IS DISCUSSING

Not all individuals with CLL need therapy. Despite all recent developments, the iwCLL even now endorses watchful observation for individuals with asymptomatic ailment.86 This advice is predicated on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,10